This player's pipeline should keep growth going over the long run.

This biotech powerhouse could maintain its strength for the long term.

In this article, we will be taking a look at the 20 Best Biotech Stocks Under $20 to Buy Now. The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of ...

Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...

Biotech hot picks spotlight Xenon, United Therapeutics and Axsome as Phase III data and FDA decisions approach.

Amicus Therapeutics FOLD and Rigel Pharmaceuticals RIGL appeal to growth-focused investors as they target rare diseases, where small patient populations can still support strong revenue growth. Amicus ...

Following recent challenges, these drugmakers could see solid clinical progress in the next 12 to 18 months. Both could launch products with significant sales potential and ride that wave through the ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it’s no mystery as to why many wish to be underweight in ...

Amicus Therapeutics, Inc. (NASDAQ:FOLD) tops our list for being one of the best biotech stocks. TheFly reported on January 22 that Jefferies downgraded FOLD to Buy from Hold and lowered the price ...